Welcome to LookChem.com Sign In|Join Free
  • or
(+/-)-2-ACETYL-9-AZA BICYCLO[4.2.1]NON-2-ENE FUMARATE is a bicyclic amine alkaloid and a cyanotoxin with acute neurotoxicity. It is a secondary metabolite produced by certain cyanobacteria genera and has been reported in various regions across the globe, including North America, Europe, Africa, Asia, and New Zealand. (+/-)-2-ACETYL-9-AZA BICYCLO[4.2.1]NON-2-ENE FUMARATE exhibits potent neurotoxic effects, posing a significant threat to both human and animal health.

64285-06-9

Post Buying Request

64285-06-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

64285-06-9 Usage

Uses

Used in Neurotoxin Research:
(+/-)-2-ACETYL-9-AZA BICYCLO[4.2.1]NON-2-ENE FUMARATE is used as a research tool in the field of neurotoxin studies. Its acute neurotoxic properties make it valuable for understanding the mechanisms of neurotoxicity and developing potential countermeasures or treatments for exposure.
Used in Environmental Monitoring and Water Quality Assessment:
Due to its presence in certain cyanobacterial blooms, (+/-)-2-ACETYL-9-AZA BICYCLO[4.2.1]NON-2-ENE FUMARATE can be used as a bioindicator for assessing water quality and monitoring the presence of harmful cyanobacterial species in aquatic ecosystems.
Used in Pharmaceutical Development:
Although (+/-)-2-ACETYL-9-AZA BICYCLO[4.2.1]NON-2-ENE FUMARATE is a toxic compound, its unique structure and biological activity may provide insights for the development of new pharmaceutical agents with targeted neurotoxic effects for specific therapeutic applications.
Used in Public Health and Safety Education:
Awareness and education about the dangers of (+/-)-2-ACETYL-9-AZA BICYCLO[4.2.1]NON-2-ENE FUMARATE and other cyanotoxins are crucial for public health and safety. (+/-)-2-ACETYL-9-AZA BICYCLO[4.2.1]NON-2-ENE FUMARATE can be used as a case study in educational programs to inform the public about the risks associated with cyanobacterial blooms and the importance of proper water treatment and management practices.

Acute toxicity

Intraperitoneal-mouse LDL0: 0.25 mg/kg

Synthesis Reference(s)

Journal of the American Chemical Society, 106, p. 4539, 1984 DOI: 10.1021/ja00328a040

Biological Activity

A potent nicotinic agonist (K i values are 1.25 and 1840 nM for α 4 β 2 and α 7 nicotinic receptors respectively). Stimulates [ 3 H]-dopamine release from rat striatal synaptosomes (EC 50 = 136 nM).

Safety Profile

Poison by intraperitoneal route.An experimental teratogen. When heated todecomposition it emits toxic fumes of NOx.

Check Digit Verification of cas no

The CAS Registry Mumber 64285-06-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,4,2,8 and 5 respectively; the second part has 2 digits, 0 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 64285-06:
(7*6)+(6*4)+(5*2)+(4*8)+(3*5)+(2*0)+(1*6)=129
129 % 10 = 9
So 64285-06-9 is a valid CAS Registry Number.
InChI:InChI=1/C10H15NO/c1-7(12)9-4-2-3-8-5-6-10(9)11-8/h4,8,10-11H,2-3,5-6H2,1H3

64285-06-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name (±)-Anatoxin A fumarate,(±)-2-Acetyl-9-azabicyclo[4.2.1]non-2-enefumarate

1.2 Other means of identification

Product number -
Other names anatoxini

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:64285-06-9 SDS

64285-06-9Synthetic route

(+)-(1R)-2-acetyl-9-benzyloxycarbonyl-9-azabicyclo[4.2.1]-2-nonene
120692-41-3

(+)-(1R)-2-acetyl-9-benzyloxycarbonyl-9-azabicyclo[4.2.1]-2-nonene

anatoxin-a
64285-06-9

anatoxin-a

Conditions
ConditionsYield
With trimethylsilyl iodide In acetonitrile at -10℃; for 0.333333h;99%
(-)-N-tosylanatoxin-a
143264-77-1

(-)-N-tosylanatoxin-a

anatoxin-a
64285-06-9

anatoxin-a

Conditions
ConditionsYield
With disodium hydrogenphosphate; sodium amalgam In methanol at -40℃; for 0.166667h;76%
(1R,6R)-2-Acetyl-9-aza-bicyclo[4.2.1]non-2-ene-9-carboxylic acid vinyl ester
216166-93-7

(1R,6R)-2-Acetyl-9-aza-bicyclo[4.2.1]non-2-ene-9-carboxylic acid vinyl ester

anatoxin-a
64285-06-9

anatoxin-a

Conditions
ConditionsYield
With hydrochloric acid diethyl ether In ethanol at 50℃;
methyl (2R)-pyroglutamate
64700-65-8

methyl (2R)-pyroglutamate

anatoxin-a
64285-06-9

anatoxin-a

Conditions
ConditionsYield
Multi-step reaction with 8 steps
1.1: 100 percent / LiHMDS / tetrahydrofuran / -78 - 20 °C
2.1: Mg / tetrahydrofuran / 0.83 h / 20 °C
2.2: 73 percent / TMEDA / tetrahydrofuran / 1.5 h / -78 °C
3.1: BF3*OEt2; Ph3SiH / CH2Cl2 / 2.5 h / -78 - 20 °C
3.2: DIBAL-H / toluene / 3 h / -78 °C
3.3: 826 mg / Cs2CO3 / toluene; propan-2-ol / 17 h / 20 °C
4.1: 97 percent / NaHMDS / tetrahydrofuran / 2 h / -78 °C
5.1: 84 percent / second generation Grubbs catalyst / CH2Cl2 / 16 h
6.1: 76 percent / Et3N; OsO4 / tetrahydrofuran / 22 h / -78 - 20 °C
7.1: 95 percent / NaIO4 / tetrahydrofuran; H2O / 1.5 h / 20 °C
8.1: 99 percent / TMSI / acetonitrile / 0.33 h / -10 °C
View Scheme
1-benzyl 2-methyl (R)-5-oxopyrrolidine-1,2-dicarboxylate
690211-34-8

1-benzyl 2-methyl (R)-5-oxopyrrolidine-1,2-dicarboxylate

anatoxin-a
64285-06-9

anatoxin-a

Conditions
ConditionsYield
Multi-step reaction with 7 steps
1.1: Mg / tetrahydrofuran / 0.83 h / 20 °C
1.2: 73 percent / TMEDA / tetrahydrofuran / 1.5 h / -78 °C
2.1: BF3*OEt2; Ph3SiH / CH2Cl2 / 2.5 h / -78 - 20 °C
2.2: DIBAL-H / toluene / 3 h / -78 °C
2.3: 826 mg / Cs2CO3 / toluene; propan-2-ol / 17 h / 20 °C
3.1: 97 percent / NaHMDS / tetrahydrofuran / 2 h / -78 °C
4.1: 84 percent / second generation Grubbs catalyst / CH2Cl2 / 16 h
5.1: 76 percent / Et3N; OsO4 / tetrahydrofuran / 22 h / -78 - 20 °C
6.1: 95 percent / NaIO4 / tetrahydrofuran; H2O / 1.5 h / 20 °C
7.1: 99 percent / TMSI / acetonitrile / 0.33 h / -10 °C
View Scheme
(2R,5R)-5-but-3-enyl-2-ethynylpyrrolidine-1-carboxylic acid 1-benzyl ester
690211-37-1

(2R,5R)-5-but-3-enyl-2-ethynylpyrrolidine-1-carboxylic acid 1-benzyl ester

anatoxin-a
64285-06-9

anatoxin-a

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: 97 percent / NaHMDS / tetrahydrofuran / 2 h / -78 °C
2: 84 percent / second generation Grubbs catalyst / CH2Cl2 / 16 h
3: 76 percent / Et3N; OsO4 / tetrahydrofuran / 22 h / -78 - 20 °C
4: 95 percent / NaIO4 / tetrahydrofuran; H2O / 1.5 h / 20 °C
5: 99 percent / TMSI / acetonitrile / 0.33 h / -10 °C
View Scheme
(2R)-but-3-enyl-(5R)-prop-1-ynylpyrrolidine-1-carboxylic acid 1-benzyl ester
690211-38-2

(2R)-but-3-enyl-(5R)-prop-1-ynylpyrrolidine-1-carboxylic acid 1-benzyl ester

anatoxin-a
64285-06-9

anatoxin-a

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 84 percent / second generation Grubbs catalyst / CH2Cl2 / 16 h
2: 76 percent / Et3N; OsO4 / tetrahydrofuran / 22 h / -78 - 20 °C
3: 95 percent / NaIO4 / tetrahydrofuran; H2O / 1.5 h / 20 °C
4: 99 percent / TMSI / acetonitrile / 0.33 h / -10 °C
View Scheme
(+)-(1R)-2-isopropenyl-9-benzyloxycarbonyl-9-azabicyclo[4.2.1]-2-nonene
690211-39-3

(+)-(1R)-2-isopropenyl-9-benzyloxycarbonyl-9-azabicyclo[4.2.1]-2-nonene

anatoxin-a
64285-06-9

anatoxin-a

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 76 percent / Et3N; OsO4 / tetrahydrofuran / 22 h / -78 - 20 °C
2: 95 percent / NaIO4 / tetrahydrofuran; H2O / 1.5 h / 20 °C
3: 99 percent / TMSI / acetonitrile / 0.33 h / -10 °C
View Scheme
(2R)-benzyloxycarbonylamino-5-oxonon-8-enoic acid methyl ester
690211-35-9

(2R)-benzyloxycarbonylamino-5-oxonon-8-enoic acid methyl ester

anatoxin-a
64285-06-9

anatoxin-a

Conditions
ConditionsYield
Multi-step reaction with 6 steps
1.1: BF3*OEt2; Ph3SiH / CH2Cl2 / 2.5 h / -78 - 20 °C
1.2: DIBAL-H / toluene / 3 h / -78 °C
1.3: 826 mg / Cs2CO3 / toluene; propan-2-ol / 17 h / 20 °C
2.1: 97 percent / NaHMDS / tetrahydrofuran / 2 h / -78 °C
3.1: 84 percent / second generation Grubbs catalyst / CH2Cl2 / 16 h
4.1: 76 percent / Et3N; OsO4 / tetrahydrofuran / 22 h / -78 - 20 °C
5.1: 95 percent / NaIO4 / tetrahydrofuran; H2O / 1.5 h / 20 °C
6.1: 99 percent / TMSI / acetonitrile / 0.33 h / -10 °C
View Scheme
(+)-(1R)-2-(1,2-dihydroxy-1-methylethyl)-9-benzyloxycarbonyl-9-azabicyclo[4.2.1]-2-nonene
690211-40-6

(+)-(1R)-2-(1,2-dihydroxy-1-methylethyl)-9-benzyloxycarbonyl-9-azabicyclo[4.2.1]-2-nonene

anatoxin-a
64285-06-9

anatoxin-a

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 95 percent / NaIO4 / tetrahydrofuran; H2O / 1.5 h / 20 °C
2: 99 percent / TMSI / acetonitrile / 0.33 h / -10 °C
View Scheme
(2R)-but-3-enyl-(5R)-2-(1-methylsiletan-1-ylethynyl)pyrrolidine-1-carboxylic acid benzyl ester
760968-59-0

(2R)-but-3-enyl-(5R)-2-(1-methylsiletan-1-ylethynyl)pyrrolidine-1-carboxylic acid benzyl ester

anatoxin-a
64285-06-9

anatoxin-a

Conditions
ConditionsYield
Multi-step reaction with 6 steps
1: 9 percent / second generation Grubbs catalyst / CH2Cl2 / 80 °C
2: 97 percent / NaHMDS / tetrahydrofuran / 2 h / -78 °C
3: 84 percent / second generation Grubbs catalyst / CH2Cl2 / 16 h
4: 76 percent / Et3N; OsO4 / tetrahydrofuran / 22 h / -78 - 20 °C
5: 95 percent / NaIO4 / tetrahydrofuran; H2O / 1.5 h / 20 °C
6: 99 percent / TMSI / acetonitrile / 0.33 h / -10 °C
View Scheme
(1R)-9-methyl-9-azabicyclo[4.2.1]nonan-2-one
126811-06-1

(1R)-9-methyl-9-azabicyclo[4.2.1]nonan-2-one

anatoxin-a
64285-06-9

anatoxin-a

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: LiN(SiMe3)2 / tetrahydrofuran / -40 °C
2: 95 percent / K2CO3 / CH2Cl2 / Heating
3: AlCl3 / 1,2-dichloro-ethane / -10 °C
4: 65 percent / LiBr, Li2CO3 / dimethylformamide / 150 °C
5: HCl*Et2O / ethanol / 50 °C
View Scheme
C12H18N2O

C12H18N2O

anatoxin-a
64285-06-9

anatoxin-a

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 95 percent / K2CO3 / CH2Cl2 / Heating
2: AlCl3 / 1,2-dichloro-ethane / -10 °C
3: 65 percent / LiBr, Li2CO3 / dimethylformamide / 150 °C
4: HCl*Et2O / ethanol / 50 °C
View Scheme
(1R,2S,6R)-2-Acetyl-2-chloro-9-aza-bicyclo[4.2.1]nonane-9-carboxylic acid vinyl ester

(1R,2S,6R)-2-Acetyl-2-chloro-9-aza-bicyclo[4.2.1]nonane-9-carboxylic acid vinyl ester

anatoxin-a
64285-06-9

anatoxin-a

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 65 percent / LiBr, Li2CO3 / dimethylformamide / 150 °C
2: HCl*Et2O / ethanol / 50 °C
View Scheme
C14H18N2O3

C14H18N2O3

anatoxin-a
64285-06-9

anatoxin-a

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: AlCl3 / 1,2-dichloro-ethane / -10 °C
2: 65 percent / LiBr, Li2CO3 / dimethylformamide / 150 °C
3: HCl*Et2O / ethanol / 50 °C
View Scheme
(-)-(5S)-5-{[(tert-butyldiphenylsilyl)oxy]methyl}-1-tosylpyrrolidin-2-one
132974-84-6

(-)-(5S)-5-{[(tert-butyldiphenylsilyl)oxy]methyl}-1-tosylpyrrolidin-2-one

anatoxin-a
64285-06-9

anatoxin-a

Conditions
ConditionsYield
Multi-step reaction with 9 steps
1: 92 percent / DIBAL / CH2Cl2 / -78 °C
2: 87 percent / PPTS / methanol
3: 96 percent / Bu4NF / tetrahydrofuran
4: 1.) BuLi / 1.) THF, -78 deg C
5: toluene / Irradiation
6: 1.) O3, 2.) Me2S / 1.) CH2Cl2, -78 deg C
7: 79 percent / NaH / tetrahydrofuran
8: 1.) HCl, 2.) DBU / 1.) CH2Cl2, MeOH, 2.) toluene, reflux
9: 76 percent / Na(Hg), Na2HPO4 / methanol / 0.17 h / -40 °C
View Scheme
Multi-step reaction with 12 steps
1: 92 percent / DIBAL / CH2Cl2 / -78 °C
2: 87 percent / PPTS / methanol
3: 96 percent / Bu4NF / tetrahydrofuran
4: 1.) BuLi / 1.) THF, -78 deg C
5: toluene / Irradiation
6: 1.) BH3*DMS, 2.) H2O2, 6M NaOH / 1.) THF
7: 1.) (COCl)2, 2.) Et3N / 1.) DMSO, 2.) CH2Cl2, -78 deg C
8: tetrahydrofuran
9: 76 percent / TiCl4 / CH2Cl2 / -78 °C
10: 71 percent / O2 / PdCl2, CuCl / dimethylformamide; H2O
11: 1.) KH, TMSCl, 2.) Et3N / 2.) Pd(OAc)2 / 2.) CH3CN
12: 76 percent / Na(Hg), Na2HPO4 / methanol / 0.17 h / -40 °C
View Scheme
[(2S,5R)-5-Methoxy-1-(toluene-4-sulfonyl)-pyrrolidin-2-yl]-methanol
143264-74-8

[(2S,5R)-5-Methoxy-1-(toluene-4-sulfonyl)-pyrrolidin-2-yl]-methanol

anatoxin-a
64285-06-9

anatoxin-a

Conditions
ConditionsYield
Multi-step reaction with 6 steps
1: 1.) BuLi / 1.) THF, -78 deg C
2: toluene / Irradiation
3: 1.) O3, 2.) Me2S / 1.) CH2Cl2, -78 deg C
4: 79 percent / NaH / tetrahydrofuran
5: 1.) HCl, 2.) DBU / 1.) CH2Cl2, MeOH, 2.) toluene, reflux
6: 76 percent / Na(Hg), Na2HPO4 / methanol / 0.17 h / -40 °C
View Scheme
Multi-step reaction with 9 steps
1: 1.) BuLi / 1.) THF, -78 deg C
2: toluene / Irradiation
3: 1.) BH3*DMS, 2.) H2O2, 6M NaOH / 1.) THF
4: 1.) (COCl)2, 2.) Et3N / 1.) DMSO, 2.) CH2Cl2, -78 deg C
5: tetrahydrofuran
6: 76 percent / TiCl4 / CH2Cl2 / -78 °C
7: 71 percent / O2 / PdCl2, CuCl / dimethylformamide; H2O
8: 1.) KH, TMSCl, 2.) Et3N / 2.) Pd(OAc)2 / 2.) CH3CN
9: 76 percent / Na(Hg), Na2HPO4 / methanol / 0.17 h / -40 °C
View Scheme
(2R,5R)-2-But-3-enyl-5-methoxy-1-(toluene-4-sulfonyl)-pyrrolidine
143264-75-9

(2R,5R)-2-But-3-enyl-5-methoxy-1-(toluene-4-sulfonyl)-pyrrolidine

anatoxin-a
64285-06-9

anatoxin-a

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 1.) O3, 2.) Me2S / 1.) CH2Cl2, -78 deg C
2: 79 percent / NaH / tetrahydrofuran
3: 1.) HCl, 2.) DBU / 1.) CH2Cl2, MeOH, 2.) toluene, reflux
4: 76 percent / Na(Hg), Na2HPO4 / methanol / 0.17 h / -40 °C
View Scheme
Multi-step reaction with 7 steps
1: 1.) BH3*DMS, 2.) H2O2, 6M NaOH / 1.) THF
2: 1.) (COCl)2, 2.) Et3N / 1.) DMSO, 2.) CH2Cl2, -78 deg C
3: tetrahydrofuran
4: 76 percent / TiCl4 / CH2Cl2 / -78 °C
5: 71 percent / O2 / PdCl2, CuCl / dimethylformamide; H2O
6: 1.) KH, TMSCl, 2.) Et3N / 2.) Pd(OAc)2 / 2.) CH3CN
7: 76 percent / Na(Hg), Na2HPO4 / methanol / 0.17 h / -40 °C
View Scheme
(1R,6R)-9-(Toluene-4-sulfonyl)-2-vinyl-9-aza-bicyclo[4.2.1]nonane
143264-80-6

(1R,6R)-9-(Toluene-4-sulfonyl)-2-vinyl-9-aza-bicyclo[4.2.1]nonane

anatoxin-a
64285-06-9

anatoxin-a

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 71 percent / O2 / PdCl2, CuCl / dimethylformamide; H2O
2: 1.) KH, TMSCl, 2.) Et3N / 2.) Pd(OAc)2 / 2.) CH3CN
3: 76 percent / Na(Hg), Na2HPO4 / methanol / 0.17 h / -40 °C
View Scheme
3-[(2S,5R)-5-Methoxy-1-(toluene-4-sulfonyl)-pyrrolidin-2-yl]-propionaldehyde

3-[(2S,5R)-5-Methoxy-1-(toluene-4-sulfonyl)-pyrrolidin-2-yl]-propionaldehyde

anatoxin-a
64285-06-9

anatoxin-a

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 79 percent / NaH / tetrahydrofuran
2: 1.) HCl, 2.) DBU / 1.) CH2Cl2, MeOH, 2.) toluene, reflux
3: 76 percent / Na(Hg), Na2HPO4 / methanol / 0.17 h / -40 °C
View Scheme
4-[(2R,5R)-5-Methoxy-1-(toluene-4-sulfonyl)-pyrrolidin-2-yl]-butan-1-ol
143264-78-2

4-[(2R,5R)-5-Methoxy-1-(toluene-4-sulfonyl)-pyrrolidin-2-yl]-butan-1-ol

anatoxin-a
64285-06-9

anatoxin-a

Conditions
ConditionsYield
Multi-step reaction with 6 steps
1: 1.) (COCl)2, 2.) Et3N / 1.) DMSO, 2.) CH2Cl2, -78 deg C
2: tetrahydrofuran
3: 76 percent / TiCl4 / CH2Cl2 / -78 °C
4: 71 percent / O2 / PdCl2, CuCl / dimethylformamide; H2O
5: 1.) KH, TMSCl, 2.) Et3N / 2.) Pd(OAc)2 / 2.) CH3CN
6: 76 percent / Na(Hg), Na2HPO4 / methanol / 0.17 h / -40 °C
View Scheme
1-[(1R,6R)-9-(Toluene-4-sulfonyl)-9-aza-bicyclo[4.2.1]non-2-yl]-ethanone

1-[(1R,6R)-9-(Toluene-4-sulfonyl)-9-aza-bicyclo[4.2.1]non-2-yl]-ethanone

anatoxin-a
64285-06-9

anatoxin-a

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 1.) KH, TMSCl, 2.) Et3N / 2.) Pd(OAc)2 / 2.) CH3CN
2: 76 percent / Na(Hg), Na2HPO4 / methanol / 0.17 h / -40 °C
View Scheme
4-[(2R,5R)-5-Methoxy-1-(toluene-4-sulfonyl)-pyrrolidin-2-yl]-butyraldehyde

4-[(2R,5R)-5-Methoxy-1-(toluene-4-sulfonyl)-pyrrolidin-2-yl]-butyraldehyde

anatoxin-a
64285-06-9

anatoxin-a

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: tetrahydrofuran
2: 76 percent / TiCl4 / CH2Cl2 / -78 °C
3: 71 percent / O2 / PdCl2, CuCl / dimethylformamide; H2O
4: 1.) KH, TMSCl, 2.) Et3N / 2.) Pd(OAc)2 / 2.) CH3CN
5: 76 percent / Na(Hg), Na2HPO4 / methanol / 0.17 h / -40 °C
View Scheme
(E)-6-[(2R,5R)-5-Methoxy-1-(toluene-4-sulfonyl)-pyrrolidin-2-yl]-hex-3-en-2-one
143264-76-0, 143292-29-9

(E)-6-[(2R,5R)-5-Methoxy-1-(toluene-4-sulfonyl)-pyrrolidin-2-yl]-hex-3-en-2-one

anatoxin-a
64285-06-9

anatoxin-a

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 1.) HCl, 2.) DBU / 1.) CH2Cl2, MeOH, 2.) toluene, reflux
2: 76 percent / Na(Hg), Na2HPO4 / methanol / 0.17 h / -40 °C
View Scheme
(2R,5R)-2-Methoxy-1-(toluene-4-sulfonyl)-5-((E)-5-trimethylsilanyl-pent-4-enyl)-pyrrolidine
143264-79-3, 143292-31-3

(2R,5R)-2-Methoxy-1-(toluene-4-sulfonyl)-5-((E)-5-trimethylsilanyl-pent-4-enyl)-pyrrolidine

anatoxin-a
64285-06-9

anatoxin-a

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 76 percent / TiCl4 / CH2Cl2 / -78 °C
2: 71 percent / O2 / PdCl2, CuCl / dimethylformamide; H2O
3: 1.) KH, TMSCl, 2.) Et3N / 2.) Pd(OAc)2 / 2.) CH3CN
4: 76 percent / Na(Hg), Na2HPO4 / methanol / 0.17 h / -40 °C
View Scheme
Thiocarbonic acid O-[(2S,5R)-5-methoxy-1-(toluene-4-sulfonyl)-pyrrolidin-2-ylmethyl] ester O-phenyl ester

Thiocarbonic acid O-[(2S,5R)-5-methoxy-1-(toluene-4-sulfonyl)-pyrrolidin-2-ylmethyl] ester O-phenyl ester

anatoxin-a
64285-06-9

anatoxin-a

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: toluene / Irradiation
2: 1.) O3, 2.) Me2S / 1.) CH2Cl2, -78 deg C
3: 79 percent / NaH / tetrahydrofuran
4: 1.) HCl, 2.) DBU / 1.) CH2Cl2, MeOH, 2.) toluene, reflux
5: 76 percent / Na(Hg), Na2HPO4 / methanol / 0.17 h / -40 °C
View Scheme
Multi-step reaction with 8 steps
1: toluene / Irradiation
2: 1.) BH3*DMS, 2.) H2O2, 6M NaOH / 1.) THF
3: 1.) (COCl)2, 2.) Et3N / 1.) DMSO, 2.) CH2Cl2, -78 deg C
4: tetrahydrofuran
5: 76 percent / TiCl4 / CH2Cl2 / -78 °C
6: 71 percent / O2 / PdCl2, CuCl / dimethylformamide; H2O
7: 1.) KH, TMSCl, 2.) Et3N / 2.) Pd(OAc)2 / 2.) CH3CN
8: 76 percent / Na(Hg), Na2HPO4 / methanol / 0.17 h / -40 °C
View Scheme
N-p-toluenesulphonyl(5-diphenyl-tert-butylsilyloxymethyl)-2-hydroxypyrrolidine
143264-72-6, 143292-32-4

N-p-toluenesulphonyl(5-diphenyl-tert-butylsilyloxymethyl)-2-hydroxypyrrolidine

anatoxin-a
64285-06-9

anatoxin-a

Conditions
ConditionsYield
Multi-step reaction with 8 steps
1: 87 percent / PPTS / methanol
2: 96 percent / Bu4NF / tetrahydrofuran
3: 1.) BuLi / 1.) THF, -78 deg C
4: toluene / Irradiation
5: 1.) O3, 2.) Me2S / 1.) CH2Cl2, -78 deg C
6: 79 percent / NaH / tetrahydrofuran
7: 1.) HCl, 2.) DBU / 1.) CH2Cl2, MeOH, 2.) toluene, reflux
8: 76 percent / Na(Hg), Na2HPO4 / methanol / 0.17 h / -40 °C
View Scheme
Multi-step reaction with 11 steps
1: 87 percent / PPTS / methanol
2: 96 percent / Bu4NF / tetrahydrofuran
3: 1.) BuLi / 1.) THF, -78 deg C
4: toluene / Irradiation
5: 1.) BH3*DMS, 2.) H2O2, 6M NaOH / 1.) THF
6: 1.) (COCl)2, 2.) Et3N / 1.) DMSO, 2.) CH2Cl2, -78 deg C
7: tetrahydrofuran
8: 76 percent / TiCl4 / CH2Cl2 / -78 °C
9: 71 percent / O2 / PdCl2, CuCl / dimethylformamide; H2O
10: 1.) KH, TMSCl, 2.) Et3N / 2.) Pd(OAc)2 / 2.) CH3CN
11: 76 percent / Na(Hg), Na2HPO4 / methanol / 0.17 h / -40 °C
View Scheme
N-p-toluenesulphonyl(5-diphenyl-tert-butylsilyloxymethyl)-2-methoxypyrrolidine
143264-73-7, 143292-30-2

N-p-toluenesulphonyl(5-diphenyl-tert-butylsilyloxymethyl)-2-methoxypyrrolidine

anatoxin-a
64285-06-9

anatoxin-a

Conditions
ConditionsYield
Multi-step reaction with 7 steps
1: 96 percent / Bu4NF / tetrahydrofuran
2: 1.) BuLi / 1.) THF, -78 deg C
3: toluene / Irradiation
4: 1.) O3, 2.) Me2S / 1.) CH2Cl2, -78 deg C
5: 79 percent / NaH / tetrahydrofuran
6: 1.) HCl, 2.) DBU / 1.) CH2Cl2, MeOH, 2.) toluene, reflux
7: 76 percent / Na(Hg), Na2HPO4 / methanol / 0.17 h / -40 °C
View Scheme
Multi-step reaction with 10 steps
1: 96 percent / Bu4NF / tetrahydrofuran
2: 1.) BuLi / 1.) THF, -78 deg C
3: toluene / Irradiation
4: 1.) BH3*DMS, 2.) H2O2, 6M NaOH / 1.) THF
5: 1.) (COCl)2, 2.) Et3N / 1.) DMSO, 2.) CH2Cl2, -78 deg C
6: tetrahydrofuran
7: 76 percent / TiCl4 / CH2Cl2 / -78 °C
8: 71 percent / O2 / PdCl2, CuCl / dimethylformamide; H2O
9: 1.) KH, TMSCl, 2.) Et3N / 2.) Pd(OAc)2 / 2.) CH3CN
10: 76 percent / Na(Hg), Na2HPO4 / methanol / 0.17 h / -40 °C
View Scheme
anatoxin-a
64285-06-9

anatoxin-a

L-N-Boc-Ala
15761-38-3

L-N-Boc-Ala

(S)-Ala-(1R)-anatoxin

(S)-Ala-(1R)-anatoxin

64285-06-9Relevant academic research and scientific papers

Efficient new syntheses of (+)and (-)-anatoxin-a. Revised configuration of resolved 9-methyl-9-azabicyclo[4.2.1]nonan-2-one

Ferguson, John R.,Lumbard, Keith W.,Scheinmann, Feodor,Stachulski, Andrew V.,Stjernloef, Peter,Sundell, Staffan

, p. 8867 - 8870 (1995)

The bicyclic ketone 2, as either enantiomer, was converted in high yield to the glycidonitrile 4 by successive base-catalysed condensation with 2-chloropropionitrile and N-dealkylation. Opening of the epoxide followed by elimination of HCl from the resulting α-chloroketone gave the enone 7 which was converted to anatoxin-a 1 by mild acidolysis. Maintenance of chiral homogeneity from both (+)- and (-)2 was demonstrated by diastereomeric amide formation from (+)- and (-)-1. However, the prior correlation of (+)- 2 with (+)- 1 was found to be incorrect; in fact (-)- 2 gives (+)- 1.

A concise asymmetric synthesis of (-)-anatoxin-a using an enantioselective enolisation strategy

Newcombe,Simpkins

, p. 831 - 832 (1995)

The unnatural enantiomer of anatoxin-a is prepared in enantiomerically pure form by a concise route involving enantioselective enolisation of a tropinone derivative by a chiral lithium amide base as the key step.

Investigation of a unified strategy for the synthesis of anatoxin analogues: Scope and limitations

Roe, Stephen J.,Hughes, David L.,Aggarwal, Pooja,Stockman, Robert A.

experimental part, p. 3775 - 3784 (2010/03/30)

Syntheses of the potent neurotoxins and biochemical probes anatoxin-a and homoanatoxin and several analogues by a combined two-directional synthesis-tandem reaction strategy are presented. Key steps include an oxidative desymmetrisation and a tandem Micha

Total synthesis of pinnamine and anatoxin-a via a common intermediate. A caveat on the anatoxin-a endgame

Hjelmgaard, Thomas,Sotofte, Inger,Tanner, David

, p. 5688 - 5697 (2007/10/03)

This paper describes the total synthesis of the naturally occurring alkaloids pinnamine (1) and anatoxin-a (2) from a common enantiomerically pure intermediate (7) easily available from pyroglutamic acid. The synthesis of enantiopure pinnamine proceeded in 10 steps and 4.8% overall yield, and the route was flexible enough to allow stereocontrolled access to a non-natural congener (5-epi-pinnamine) of the natural product. Intramolecular reaction of an N-acyl iminium ion was a key step in the synthesis of both pinnamine and anatoxin-a. However, in stark contrast to literature precedent, complete racemization was observed during the reaction of the N-acyliminium ion leading to the latter alkaloid.

Enantioselective synthesis of (+)-anatoxin-a via enyne metathesis

Brenneman, Jehrod B.,Machauer, Rainer,Martin, Stephen F.

, p. 7301 - 7314 (2007/10/03)

A concise synthesis of the potent nAChR agonist (+)-anatoxin-a (1) has been completed by a series of nine chemical operations and in 27% overall yield from commercially available D-methyl pyroglutamate (12). The strategy featured the application of a new protocol for the diastereoselective synthesis of cis-2,5-disubstituted pyrrolidines bearing unsaturated side chains and an intramolecular enyne metathesis to provide the bridged bicyclic framework of 1. Thus, D-methyl pyroglutamate (12) was converted in five steps to 32, which underwent facile enyne metathesis to deliver the bicyclic diene 33. Selective oxidative cleavage of the less substituted carbon-carbon double bond in 33 followed by deprotection furnished (+)-anatoxin-a (1).

Synthesis of (±)-anatoxin-α and analogues

Parsons, Philip J.,Camp, Nicholas P.,Edwards, Neil,Ravi Sumoreeah

, p. 309 - 315 (2007/10/03)

A new and highly efficient synthesis of the potent nicotinic acetylcholine receptor agonist, anatoxin-α and its analogues is described, which uses a β-lactam ring opening-transannular cyclisation sequence to set up the bridged bicyclic framework of the natural product. The synthesis involves a cycloaddition of chlorosulfonyl isocyanate with cyclooctadiene followed by Boc protection of the resulting β-lactam. Reaction of the β- lactam with a variety of nucleophiles, followed by selenium-mediated cyclisation and oxidation gave the skeleton of anatoxin-α bearing various sidechains. The approach offers a flexible entry to useful quantities of anatoxin-α and its analogues.

Tandem reactions of anions: A short and efficient route to ±anatoxin-a

Parsons, Philip J.,Camp, Nicholas P.,Underwood, J. Mark,Harvey, Darren M.

, p. 11637 - 11642 (2007/10/03)

A new route to anatoxin-a (1) is reported which involves an anionically induced small ring opening/ring closure/ring opening cascade. The azabicyclo [4.2.1]nonane ring system of anatoxin-α is hence formed in one synthetic operation.

A short and enantioselective synthesis of (+)-Anatoxin-a

Somfai,Ahman

, p. 3791 - 3794 (2007/10/02)

A short and enantioselective total synthesis of the neurotoxic alkaloid (+)-Anatoxin-a (1) from the L-pyroglutamic acid derivative 2 is described. The key step involves an intramolecular cyclisation of an N-tosyl iminium ion derived from the corresponding α-methoxy sulfonamide.

A New Method of Formation of 9-Azabicyclononane Skeleton and Its Application to Synthesis of (+/-)-Anatoxin a

Shono, Tatsuya,Matsumura, Yoshihiro,Uchida, Kenshi,Tagami, Katsumi

, p. 919 - 922 (2007/10/02)

9-Azabicyclo-nonane skeleton was formed in one step by Lewis acid promoted reaction between 1-methoxycarbonyl-2,5-dimethoxypyrrolidine and 1-ethoxy-1-trimethylsiloxy-1,4-pentadiene, and it was converted to (+/-)-anatoxin a.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 64285-06-9